Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Pharmability AB
AB
Active
Org 5591490213
Alviksvägen 1, 167 53
Bromma
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
1 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharmability AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
6M
13M
19M
25M
0M
2021
0M
2022
0M
2023
0M
2024
22M
2025
EBITDA
SEK millions
0M
-3M
-5M
-8M
-10M
-3M
2021
-2M
+33%
2022
-8M
-300%
2023
-2M
+75%
2024
-3M
-50%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
21 631
Staff expenses
—
—
—
—
−1 293
EBITDA
−2 510
−2 362
−8 328
−2 287
−2 658
Depreciation & amort.
−355
−407
−398
−355
−271
EBIT
−2 865
−2 769
−8 726
−2 642
−2 929
Net financials
—
−1
2
−11
85
Profit before tax
−2 865
−2 770
−8 724
−2 653
−2 844
Tax
−0
−0
−0
−0
—
Net profit
−2 865
−2 770
−8 724
−2 653
−2 844
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
8 069
5 257
2 685
12 862
44 466
Equity
7 930
5 160
2 436
1 687
41 479
Long-term debt
0
0
0
247
297
Short-term debt
139
96
249
10 929
2 690
Total debt
139
96
249
11 176
2 987
Financial ratios
5-year trend
EBITDA-margin
-12.3%
This company
15.8%
Market median
-178% vs market
2021
2025
Soliditetsgrad
93.3%
This company
38.2%
Market median
+144% vs market
2021
2025
Egenkapitalforrentning
-6.9%
This company
18.4%
Market median
-138% vs market
2021
2025
Nettoresultatgrad
-13.1%
This company
8.1%
Market median
-262% vs market
2021
2025
Aktivomsætning
0.49×
This company
1.12×
Market median
-56% vs market
2021
2025
Gæld/egenkapital
0.07×
This company
0.62×
Market median
+89% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmability AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
